Cargando…

Inhibition of In Vitro Clostridioides difficile Biofilm Formation by the Probiotic Yeast Saccharomyces boulardii CNCM I-745 through Modification of the Extracellular Matrix Composition

Clostridioides difficile is responsible for post-antibiotic diarrhea and most of the pseudomembranous colitis cases. Multiple recurrences, one of the major challenges faced in C. difficile infection (CDI) management, can be considered as chronic infections, and the role of biofilm formation in CDI r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacotte, Pierre-Alexandre, Simons, Alexis, Bouttier, Sylvie, Malet-Villemagne, Jeanne, Nicolas, Valérie, Janoir, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227484/ https://www.ncbi.nlm.nih.gov/pubmed/35744599 http://dx.doi.org/10.3390/microorganisms10061082

Ejemplares similares

Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review
por: Gopalan, Sarath, et al.
Publicado: (2023)

Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system
por: Stier, Heike, et al.
Publicado: (2016)

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections
por: Czerucka, Dorota, et al.
Publicado: (2019)

Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS
por: Brun, Paola, et al.
Publicado: (2017)

Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases
por: Kaźmierczak-Siedlecka, Karolina, et al.
Publicado: (2020)

Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis
por: Madel, Maria-Bernadette, et al.
Publicado: (2023)

The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children
por: Bin, Zhang, et al.
Publicado: (2015)

Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS
por: Brun, Paola, et al.
Publicado: (2017)

Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review
por: Moré, Margret I, et al.
Publicado: (2018)

Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption
por: Terciolo, Chloe, et al.
Publicado: (2019)

Effect of Chilled Storage on Antioxidant Capacities and Volatile Flavors of Synbiotic Yogurt Made with Probiotic Yeast Saccharomyces boulardii CNCM I-745 in Combination with Inulin
por: Sarwar, Abid, et al.
Publicado: (2022)

The Saccharomyces boulardii CNCM I-745 Strain Shows Protective Effects against the B. anthracis LT Toxin
por: Pontier-Bres, Rodolphe, et al.
Publicado: (2015)

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review
por: Moré, Margret I, et al.
Publicado: (2015)

Saccharomyces boulardii CNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy Volunteers
por: Kelly, Ciaran Patrick, et al.
Publicado: (2019)

Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiota
por: Spatz, Madeleine, et al.
Publicado: (2023)

Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis
por: Altcheh, Jaime, et al.
Publicado: (2022)

Effects of Probiotic Fermented Fruit Juice-Based Biotransformation by Lactic Acid Bacteria and Saccharomyces boulardii CNCM I-745 on Anti-Salmonella and Antioxidative Properties
por: Laosee, Wanida, et al.
Publicado: (2022)

Effectiveness of Saccharomyces Boulardii CNCM I-745 probiotic in acute inflammatory viral diarrhoea in adults: results from a single-centre randomized trial
por: Salazar-Parra, Marcela AG, et al.
Publicado: (2023)

Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers
por: Kabbani, Toufic A., et al.
Publicado: (2016)

Saccharomyces boulardii Strain CNCM I-745 Modifies the Mononuclear Phagocytes Response in the Small Intestine of Mice Following Salmonella Typhimurium Infection
por: Ibáñez, Lidia, et al.
Publicado: (2019)

Retrospective analysis of EMR database to assess the effectiveness of Saccharomyces boulardii CNCM I-745 in children with acute diarrhoea during routine clinical practice
por: Ragavan, P.S.K., et al.
Publicado: (2020)

Polysaccharide II Surface Anchoring, the Achilles’ Heel of Clostridioides difficile
por: Malet-Villemagne, Jeanne, et al.
Publicado: (2023)

UPLC-Q-TOF-MS based metabolomics and chemometric analyses for green tea fermented with Saccharomyces boulardii CNCM I-745 and Lactiplantibacillus plantarum 299V
por: Wang, Rui, et al.
Publicado: (2022)

Influence of Three Probiotics Strains, Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. Lactis BB-12 and Saccharomyces boulardii CNCM I-745 on the Biochemical and Haematological Profiles and Body Weight of Healthy Rabbits
por: Kadja, Louiza, et al.
Publicado: (2021)

Biofilm Structures in a Mono-Associated Mouse Model of Clostridium difficile Infection
por: Soavelomandroso, Anna P., et al.
Publicado: (2017)

Evaluation of nutritional and physicochemical characteristics of soy yogurt by Lactobacillus plantarum KU985432 and Saccharomyces boulardii CNCMI-745
por: Mehaya, Fathy M., et al.
Publicado: (2023)

Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
por: Sulik-Tyszka, Beata, et al.
Publicado: (2017)

Modification of Salmonella Typhimurium Motility by the Probiotic Yeast Strain Saccharomyces boulardii
por: Pontier-Bres, Rodolphe, et al.
Publicado: (2012)

Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System
por: Hudson, Lauren E., et al.
Publicado: (2016)

Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii
por: Khatri, Indu, et al.
Publicado: (2017)

Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?
por: Pais, Pedro, et al.
Publicado: (2020)

Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardii
por: Hudson, Lauren E., et al.
Publicado: (2014)

Heterologous Expression of the Leuconostoc Bacteriocin Leucocin C in Probiotic Yeast Saccharomyces boulardii
por: Li, Ran, et al.
Publicado: (2020)

Development and Characterization of Probiotic Beers with Saccharomyces boulardii as an Alternative to Conventional Brewer’s Yeast
por: Díaz, Ana Belén, et al.
Publicado: (2023)

Impact of Subinhibitory Concentrations of Metronidazole on Morphology, Motility, Biofilm Formation and Colonization of Clostridioides difficile
por: Doan, Tri-Hanh-Dung, et al.
Publicado: (2022)

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment
por: Appel-da-Silva, Marcelo C., et al.
Publicado: (2017)

The Clostridium difficile Protease Cwp84 Modulates both Biofilm Formation and Cell-Surface Properties
por: Pantaléon, Véronique, et al.
Publicado: (2015)

Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii
por: Khatri, Indu, et al.
Publicado: (2013)

Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates (Saccharomyces ‘boulardii’)
por: Imre, Alexandra, et al.
Publicado: (2021)

Growth Parameters and Survivability of Saccharomyces boulardii for Probiotic Alcoholic Beverages Development
por: de Paula, Breno Pereira, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_frfam8g4pkc39hftuh2i5strqk